卵巢高级别浆液性癌伴卵黄囊瘤成分1例
A Case of High-Grade Serous Carcinoma of Ovary with Yolk Sac Tumor Component
DOI: 10.12677/ACM.2023.1371670, PDF,   
作者: 刘伟娜：郑州大学第二附属医院妇产科，河南 郑州；李 辉, 冯 燕, 陈小辉*：河南省人民医院妇科，河南 郑州；范盼红, 周胜理：河南省人民医院病理科，河南 郑州；李 攀：河南省人民医院影像科，河南 郑州
关键词: 卵巢；卵巢癌；高级别浆液性癌；卵黄囊瘤；Ovary； Ovarian Cancer； High-Grade Serous Carcinoma； Yolk Sac Tumor
摘要: 目的：探究卵巢高级别浆液性癌伴卵黄囊改变的临床治疗方式及相关预后情况。方法：通过报道笔者收治的一例卵巢高级别浆液性癌伴卵黄囊瘤改变IIA期的临床诊治过程及随访，并回顾性分析国内外相关文献报道，总结卵巢高级别浆液性癌伴卵黄囊改变的病例特点、治疗方式及预后。结果：伴有卵黄囊瘤成分的卵巢上皮性肿瘤，侵袭能力强，预后极差，因此应引起妇科医生高度重视。
Abstract: Objective: To investigate the clinical treatment and prognosis of high-grade serous carcinoma of ovary with yolk sac changes. Methods: Through reporting the clinical treatment and follow-up of a case of high-grade serous carcinoma of ovary with yolk sac changes stage IIA admitted by the author, and retrospectively analyzing the relevant literature reports at home and abroad, we summarized the case characteristics, treatment and prognosis of high-grade serous carcinoma of ovary with yolk sac changes. Results: Ovarian epithelial tumors with yolk sac components are highly invasive and have a very poor prognosis, therefore, they should be highly valued by gynecologists.
文章引用：刘伟娜, 李辉, 冯燕, 范盼红, 周胜理, 李攀, 陈小辉. 卵巢高级别浆液性癌伴卵黄囊瘤成分1例[J]. 临床医学进展, 2023, 13(7): 11918-11924. https://doi.org/10.12677/ACM.2023.1371670

参考文献

[1] 周琦, 吴小华, 刘继红, 等. 中国卵巢上皮性癌维持治疗专家共识(2020) [J]. 中国实用妇科与产科杂志, 2020(3): 234-238.
[2] Höhn, A.K., Brambs, C.E., Hiller, G.G.R., et al. (2021) 2020 WHO Classification of Female Genital Tumors. Geburtshilfe Frauenheilkd, 81, 1145-1153. [Google Scholar] [CrossRef] [PubMed]
[3] García-Galvis, O.F., Cabrera-Ozoria, C., Fernández, J.A., et al. (2008) Malignant Müllerian Mixed Tumor of the Ovary Associated with Yolk Sac Tumor, Neuroepithelial and Trophoblastic Differentiation (Teratoid Carcinosarcoma). International Journal of Gy-necological Pathology, 27, 515-520. [Google Scholar] [CrossRef] 
[4] Giuliani, J., Marzola, M., Pizzutilo, P., Martinello, R., Marzola, A., Indelli, M. and Frassoldati, A. (2012) Ovarian Endometrioid Adenocarci-noma with a Yolk Sac Tumor Component in a Postmenopausal Woman: Case Report and Review of the Literature. Clin-ical Ovarian and Other Gynecologic Cancer, 5, 31-32. [Google Scholar] [CrossRef] 
[5] Varia, M., Mccluggage, W.G. and Oommen, R. (2012) High Grade Serous Carcinoma of the Ovary with a Yolk Sac Tumour Component in a Postmenopausal Woman: Report of an Extremely Rare Phenomenon. Journal of Clinical Pathology, 65, 853. [Google Scholar] [CrossRef] [PubMed]
[6] Roma, A.A. and Przybycin, C.G. (2014) Yolk Sac Tumor in Postmenopausal Patients: Pure or Associated with Adenocarcinoma, a Rare Phenomenon. International Journal of Gy-necological Pathology, 33, 477-482. [Google Scholar] [CrossRef] 
[7] Chen, Q. and Chen, X. (2014) Bilateral Ovarian Mixed Epi-thelial Adenocarcinoma in a Postmenopausal Woman with Unilateral Ovarian Yolk Sac Tumor Component. International Journal of Clinical and Experimental Pathology, 7, 8259-8265.
[8] Mccarthy, W.A. and Masand, R.P. (2016) Ovarian Yolk Sac Tumor with High-Grade Serous Carcinoma in a 62-Year-Old Woman. International Journal of Surgical Pa-thology, 24, 360-365. [Google Scholar] [CrossRef] [PubMed]
[9] Mcnamee, T., Damato, S. and Mccluggage, W.G. (2016) Yolk Sac Tumours of the Female Genital Tract in Older Adults Derive Commonly from Somatic Epithelial Neoplasms: Somat-ically Derived Yolk Sac Tumours. Histopathology, 69, 739-751. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, Y., et al. (2018) Ovarian Yolk Sac Tumor in Postmenopausal Females: A Case Series and a Literature Review. Medicine, 97, e11838,, [Google Scholar] [CrossRef] 
[11] Xing, F., Jiang, L., Wang, T., et al. (2020) High-Grade Serous Carcinoma of Fallopian Tube with Yolk Sac Tumor Differentiation in a Postmenopausal Patient. In-ternational Journal of Clinical and Experimental Pathology, 13, 1415-1420.
[12] 钞晓培, 谭先杰. 卵巢上皮性肿瘤起源的卵黄囊瘤诊治[J]. 中国实用妇科与产科杂志, 2018, 34(5): 569-572.
[13] Rutgers, J.L., Young, R.H. and Scully, R.E. (1987) Ovarian Yolk Sac Tumor Arising from an Endometrioid Carcinoma. Human Pathology, 18, 1296-1299. [Google Scholar] [CrossRef] 
[14] Abe, A., Furumoto, H., Yoshida, K., et al. (2008) A Case of Ovarian Endometrioid Adenocarcinoma with a Yolk Sac Tumor Component. International Journal of Gyne-cologic Cancer, 18, 168-172.
[15] Skala, S.L., Liu, C.J., Udager, A.M., et al. (2020) Molecular Characterization of Uterine and Ovarian Tumors with Mixed Epithelial and Germ Cell Features Confirms Frequent somatic Derivation. Modern Pathology, 33, 1989-2000.
[16] Acosta, A.M., Sholl, L.M., Cin, P.D., Howitt, B.E., Otis, C.N. and Nucci, M.R. (2020) Malignant Tumours of the Uterus and Ovaries with Mullerian and Germ Cell or Trophoblastic Components Have a Somatic Origin and Are Characterised by Genomic Instability. Histopathology, 77, 788-797. [Google Scholar] [CrossRef] [PubMed]
[17] 霍真, 李文琴, 马水清, 等. 伴有卵黄囊瘤成分的卵巢上皮性肿瘤临床病理特点分析[J]. 诊断病理学杂志, 2017, 24(12): 897-902, 907.
[18] 钞晓培, 谭先杰. 子宫内膜原发卵黄囊瘤诊治进展[J]. 现代妇产科进展, 2018, 27(4): 303-304, 307.
[19] Nogales, F.F., Dulcey, I. and Preda, O. (2014) Germ Cell Tumors of the Ovary: An Update. Archives of Pathology & Laboratory Medicine, 138, 351-362. [Google Scholar] [CrossRef] 
[20] 葛丽萍, 刘爱军. 卵巢恶性生殖细胞肿瘤的免疫组化诊断进展——SALL4及其他标记物的联合应用[J]. 现代妇产科进展, 2015(2): 143-145.
[21] Roth, L.M., Talerman, A., Levy, T., et al. (2011) Ovarian Yolk Sac Tumors in Older Women Arising from Epithelial Ovarian Tumors or with No Detectable Epithelial Component. International Journal of Gynecological Pathology, 30, 442-451. [Google Scholar] [CrossRef] 
[22] Cao, D., Guo, S., Allan, R.W., et al. (2009) SALL4 Is a Novel Sensitive and Specific Marker of Ovarian Primitive Germ Cell Tumors and Is Particularly Useful in Distinguishing Yolk Sac Tumor from Clear Cell Carcinoma. The American Journal of Surgical Pathology, 33, 894-904. [Google Scholar] [CrossRef] 
[23] Nogales, F.F., Bergeron, C., Carvia, R.E., Alvaro, T. and Fulwood, H. (1996) Ovarian Endometrioid Tumors with Yolk Sac Tumor Component, an Unusual Form of Ovarian Neoplasm. Analysis of Six Cases. The American Journal of Surgical Pathology, 20, 1056-1066. [Google Scholar] [CrossRef] [PubMed]
[24] Hodgson, A., Ghorab, Z. and Parra-Herran, C. (2021) Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman. International Journal of Gynecological Pathol-ogy, 40, 296-300. [Google Scholar] [CrossRef] 
[25] Chen, J., Wang, J., Cao, D., et al. (2021) α-Fetoprotein (AFP)-Producing Epithelial Ovarian Carcinoma (EOC): A Retrospective Study of 27 Cases. Archives of Gynecology and Obstetrics, 304, 1043-1053. [Google Scholar] [CrossRef] [PubMed]

为你推荐